Lisa A. De Stefano, Hyeonseok Kim, Craig A. Erickson, Ernest V. Pedapati, Kelli C. Dominick, Rebecca Shaffer, Logan K. Wink, Lauren M. Schmitt, Makoto Miyakoshi. "Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome." Scientific Reports, 2026. doi:10.1038/s41598-026-44380-0